Lung Cancer Network Malaysia Confers Inaugural World Cancer Day Awards on Two Eminent Senior Professors 
LCNM Conducts First AI Lung Cancer Screening in Johor 
A Call to Action On World Lung Cancer Day – A Time of Hope, Concern & Action – Lung Cancer Network Malaysia 
Innovating for a Greener Future: The Rise of Plant-Based Wellness Products 
Wandong Medical Attains MDR Certification for Seven Key Product Series 
ASEAN Accepts Mutually Recognised COVID-19 Vaccination Certificates
ASEAN Member States collectively recognize the COVID-19 vaccination certificate to be applied in Southeast Asia. Health Ministers of ASEAN countries...
New Therapeutic Option to Reduce Risk of Cardiovascular Deaths and Repeated Hospitalisations Among Adult Heart Failure Patients Approved in Singapore
Bayer's VERQUVO™ (vericiguat), a soluble guanylate cyclase (sGC) stimulator, has been approved in Singapore for the treatment of symptomatic chronic...
GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region
On the May 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO company from GenScript Biotech Corporation, today...
Bora Pharmaceuticals acquires Eden Biologics CDMO Assets
Taiwan-based premier international contract development and manufacturing organization (CDMO) Bora Pharmaceuticals recently announced the establishment of Bora Biologics Co., Ltd.,...
Ascletis Announces U.S. IND Approval of ASC22 (Envafolimab) for Immune Restoration/Functional Cure of HIV-1 Infected Patients
Ascletis Pharma Inc. announces today the Investigational New Drug (IND) application approval of ASC22 (Envafolimab) by U.S. Food and Drug...
A Nurse’s Story: How I Learned My Specialty
Nurses are said to be the pillars, the backbone and the biggest support system of the healthcare industry; and there...
InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug resistance for hard-to-treat...
Brii Bio Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Omicron BA.2 Subvariant
Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a multi-national company developing innovative therapies for diseases with...
OMRON Healthcare Unveils Long-term Corporate Vision, “Going for ZERO, Preventive Care for Health of Society”
In March 2022, OMRON Group announced a new long-term vision, "Shaping the Future 2030" (hereafter referred to as SF2030). In...
Obesity Epidemic Impacts on Fertility, but Denying Women Treatment Based on Weight is Discriminatory
The worldwide increase in the prevalence of female and male obesity is having a profound impact on general health and...
